Insider · CIK 0001250316
SCHEINBERG DAVID A
Reports to the SEC for 3 companies · NEW YORK, NY
Transactions
50
Companies
3
Filings
15
CIK
0001250316
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-01-07 | SLSSELLAS Life Sciences Group, Inc.A Award | — |
| 2025-01-10 | SLSSELLAS Life Sciences Group, Inc.A Award | — |
| 2025-01-10 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-01-22 | SLSSELLAS Life Sciences Group, Inc.A Award | — |
| 2024-01-22 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-02-02 | SLSSELLAS Life Sciences Group, Inc.A Award | — |
| 2023-02-02 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-01-31 | SLSSELLAS Life Sciences Group, Inc.A Award | — |
| 2022-01-31 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-03-04 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-03-12 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-07-11 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (Right to Buy)A Award | — |
| 2019-07-01 | PROGENICS PHARMACEUTICALS INCM Exercise/Conversion | +$53.3K |
| 2019-07-01 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2019-03-14 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2018-06-13 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (Right to Buy)A Award | — |
| 2018-06-12 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2018-03-13 | SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2017-12-29 | SLSSELLAS Life Sciences Group, Inc.A Award | — |
| 2017-12-29 | SLSSELLAS Life Sciences Group, Inc.A Award | — |
| 2017-06-14 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (Right to Buy)A Award | — |
| 2016-06-08 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (Right to Buy)A Award | — |
| 2015-06-10 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award | +$134K |
| 2013-06-12 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award | +$95.2K |
| 2013-03-22 | PROGENICS PHARMACEUTICALS INCM Exercise/Conversion | +$3,086.25 |
| 2013-03-22 | PROGENICS PHARMACEUTICALS INCM Exercise/Conversion | −$6,011.25 |
| 2013-03-21 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion | +$3,086.25 |
| 2012-06-13 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award | +$79.3K |
| 2012-02-23 | PROGENICS PHARMACEUTICALS INCM Exercise/Conversion | +$8,625 |
| 2012-02-23 | PROGENICS PHARMACEUTICALS INCS Sale | −$12.5K |
| 2012-02-23 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion | +$8,625 |
| 2012-02-23 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion | −$12.5K |
| 2011-07-01 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award | — |
| 2010-07-01 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award | — |
| 2009-07-01 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award | — |
| 2008-07-01 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award | — |
| 2007-07-02 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award | — |
| 2007-07-02 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award | — |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCM Exercise/Conversion | +$40K |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCS Sale | −$302K |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCM Exercise/Conversion | +$40K |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCS Sale | −$301K |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCM Exercise/Conversion | +$20K |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCS Sale | −$150K |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCM Exercise/Conversion | +$20K |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCS Sale | −$150K |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2007-02-02 | PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
Recent filings
- 4SCHEINBERG DAVID A0001104659-26-002509SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001104659-25-003499SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001104659-24-006407SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001104659-23-010619SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001104659-22-010393SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001104659-21-033301SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001104659-20-034285SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001562180-19-003935SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001562180-19-003828SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0000899243-19-008207SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001562180-18-002997SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001209191-18-037555SEC(opens sec.gov)
- 4/ASCHEINBERG DAVID A0001209191-18-020187SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001209191-18-020018SEC(opens sec.gov)
- 4SCHEINBERG DAVID A0001209191-17-067659SEC(opens sec.gov)
Companies
Address
C/O SELLAS LIFE SCIENCES GROUP, INC., 7 TIMES SQUARE, SUITE 2503
NEW YORK, NY, 10036